FDA Inspection 1259270 — Hubei Yitai Pharmaceutical Co., Ltd
The FDA completed an inspection of Hubei Yitai Pharmaceutical Co., Ltd on Dec 13, 2024 in Tianmen. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI)
- End Date
- Dec 13, 2024
- Fiscal Year
- 2025
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Tianmen (China)